查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球纖維母細胞生長因子市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按產品、按應用、按最終用戶、按地區
市場調查報告書
商品編碼
1385640

全球纖維母細胞生長因子市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按產品、按應用、按最終用戶、按地區

Fibroblast Growth Factors Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 235 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

預計2024年全球纖維母細胞生長因子（FGF）市場規模將達到2.8億美元，未來10年預計將強勁成長。 該市場預計將以 8.64% 的複合年增長率成長，到 2031 年底將達到 5 億美元。 FGF 在細胞增殖、分化、傷口癒合和組織維護中發揮著至關重要的作用，使其在各種醫療應用中至關重要。

FGF 在醫學治療中變得越來越重要，特別是在皮膚、肌肉、肌腱、骨骼、牙齒和神經等組織的再生和癒合方面。 將 FGF 與幹細胞和特殊材料結合有可能徹底改變損傷和疾病的恢復過程。

分子科學的進步使人們對傷口癒合機制有了全面的了解。 這些知識有望為無疤痕傷口癒合和幹細胞前體組織移植鋪平道路，從而改善患者護理。

在美國，各種癌症正在迅速增加，這推動了對 FGF 的需求，尤其是在癌症治療方面。 乳癌和胃癌的流行對這項需求做出了重大貢獻。

德國處於生物技術和再生醫學的前沿，並專注於 FGF 的變革潛力。 學術界、生物技術公司和政府機構之間的合作研究正在推動對 FGF 的需求，特別是在慢性傷口、肌肉骨骼疾病和神經系統疾病的治療方面。

本報告調查了全球纖維母細胞生長因子市場，並提供了市場概述，以及按產品、應用、最終用戶、地區劃分的趨勢以及進入市場的公司的競爭趨勢。

目錄

第 1 章執行摘要

第二章市場概述

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影響分析
  • 烏克蘭和俄羅斯之間衝突的影響
  • 經濟概況
  • 杵分析

第 3 章2018-2031 年全球纖維母細胞生長因子市場展望

  • 2018-2031 年全球纖維母細胞生長因子市場展望（按產品、價值（百萬美元））
  • 2018-2031 年全球纖維母細胞生長因子市場前景（按應用、價值（百萬美元））
  • 2018-2031 年全球纖維母細胞生長因子市場前景（按最終用戶劃分）價值（百萬美元）
  • 2018-2031 年全球纖維母細胞生長因子市場前景（按地區、價值（百萬美元））

第 4 章北美纖維母細胞生長因子市場展望，2018-2031

第五章歐洲纖維母細胞生長因子市場展望，2018-2031

第 6 章亞太地區纖維母細胞生長因子市場展望，2018-2031

第 7 章拉丁美洲纖維母細胞生長因子市場展望，2018-2031

第 8 章中東與非洲纖維母細胞生長因子市場展望，2018-2031

第九章競爭態勢

  • 以最終使用者和使用情況劃分的熱圖
  • 2023 年公司市佔率分析
  • 競爭力儀表板
  • 公司簡介
    • Thermo Fisher Scientific
    • Sigma-Aldrich (now part of Merck KGaA)
    • PeproTech
    • R&D Systems (a Bio-Techne brand)
    • Abcam
    • Cell Signaling Technology
    • Novus Biologicals

第 10 章附錄

簡介目錄

The global fibroblast growth factors (FGFs) market, which was valued at $280 million in 2024, is expected to experience robust growth over the next decade, with a projected CAGR of 8.64%. By the end of 2031, the market is anticipated to reach a valuation of $500 million. FGFs play a pivotal role in cellular proliferation, differentiation, wound healing, and tissue maintenance, making them crucial in various medical applications.

The Rising Significance of FGFs in the Medical Field

FGFs have gained increasing importance in medical treatments, particularly in regenerating and healing tissues such as skin, muscles, tendons, bones, teeth, and nerves. The combination of FGFs with stem cells and specialized materials holds the potential to revolutionize the recovery process from injuries and diseases.

Factors Boosting the Importance of Fibroblast Growth Factors

In-Depth Understanding of Wound Healing Mechanisms: Advances in molecular science have led to a comprehensive understanding of wound healing mechanisms. This knowledge is expected to pave the way for scar-free wound healing and tissue transplantation from stem cell precursors, enhancing patient care.

Challenges Hindering Sales Growth of Fibroblast Growth Factors

High Development and Production Costs: The complex process of developing and producing FGFs involves significant financial investments. From extensive research to preclinical testing and clinical trials, the costs associated with FGF development pose challenges to their widespread adoption.

Country-Specific Insights

United States: The United States is experiencing a surge in various carcinomas, driving the demand for FGFs, especially in cancer treatment. The prevalence of breast and stomach cancers has significantly contributed to this demand.

According to the American Society of Clinical Oncology (ASCO), approximately 297,790 women in the U.S. are expected to be diagnosed with invasive breast cancer in 2023. Additionally, stomach cancer cases are projected to reach around 26,500, with 15,930 in men and 10,570 in women in 2022.

The need for fibroblast growth factors and cytokines in the treatment of various carcinomas, coupled with government initiatives to promote research, is propelling the demand for FGFs in the United States.

Germany: Germany is at the forefront of biotechnology and regenerative medicine, focusing on the transformative potential of FGFs. Collaborations between academia, biotech companies, and government bodies are driving demand for FGFs, particularly in the treatment of chronic wounds, musculoskeletal disorders, and neurological conditions.

China: FGFs are emerging as promising targets for cancer treatment in China. Researchers are exploring FGFs' potential to disrupt tumor growth and angiogenesis, offering new avenues for cancer therapies. The country's robust biopharmaceutical industry and collaborative research initiatives are accelerating the development of FGF-targeted therapies.

Competition Landscape

The global fibroblast growth factors market is characterized by a consolidated competitive landscape, with a few key players offering products and services on a global scale. Companies in this market are focusing on research and development, product launches, and strategic mergers to meet customer expectations and strengthen their market position.

Key Companies in the Market

  • Thermo Fisher Scientific
  • Sigma-Aldrich (now part of Merck KGaA)
  • PeproTech
  • R&D Systems (a Bio-Techne brand)
  • Abcam
  • Cell Signaling Technology
  • Novus Biologicals

Key Segments of Fibroblast Growth Factors Industry Research

Product:

  • FGF1
  • FGF2
  • FGF3
  • FGF4
  • FGF7
  • FGF10
  • FGF11
  • FGF12
  • FGF13
  • FGF14
  • FGF15
  • FGF18
  • FGF19
  • FGF20
  • FGF23
  • Others

Application:

  • Oncology
  • Hematology
  • Wound Healing
  • Dermatology
  • Cardiovascular Disease & Diabetes
  • Cell Culture
  • Others

End User:

  • Pharmaceutical & Biotechnology Companies
  • Research Centers & Academic Institutes
  • CMOs & CDMOs

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Fibroblast Growth Factors Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Fibroblast Growth Factors Market Outlook, 2018 - 2031

  • 3.1. Global Fibroblast Growth Factors Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. FGF1
      • 3.1.1.2. FGF2
      • 3.1.1.3. FGF3
      • 3.1.1.4. FGF4
      • 3.1.1.5. FGF7
      • 3.1.1.6. FGF10
      • 3.1.1.7. FGF11
      • 3.1.1.8. FGF12
      • 3.1.1.9. FGF13
      • 3.1.1.10. FGF14
      • 3.1.1.11. FGF15
      • 3.1.1.12. FGF18
      • 3.1.1.13. FGF19
      • 3.1.1.14. FGF20
      • 3.1.1.15. FGF23
      • 3.1.1.16. Others
  • 3.2. Global Fibroblast Growth Factors Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Oncology
      • 3.2.1.2. Hematology
      • 3.2.1.3. Wound Healing
      • 3.2.1.4. Dermatology
      • 3.2.1.5. Cardiovascular Disease & Diabetes
      • 3.2.1.6. Cell Culture
      • 3.2.1.7. Others
  • 3.3. Global Fibroblast Growth Factors Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Pharmaceutical & Biotechnology Companies
      • 3.3.1.2. Research Centers & Academic Institutes
      • 3.3.1.3. CMOs & CDMOs
  • 3.4. Global Fibroblast Growth Factors Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Fibroblast Growth Factors Market Outlook, 2018 - 2031

  • 4.1. North America Fibroblast Growth Factors Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. FGF1
      • 4.1.1.2. FGF2
      • 4.1.1.3. FGF3
      • 4.1.1.4. FGF4
      • 4.1.1.5. FGF7
      • 4.1.1.6. FGF10
      • 4.1.1.7. FGF11
      • 4.1.1.8. FGF12
      • 4.1.1.9. FGF13
      • 4.1.1.10. FGF14
      • 4.1.1.11. FGF15
      • 4.1.1.12. FGF18
      • 4.1.1.13. FGF19
      • 4.1.1.14. FGF20
      • 4.1.1.15. FGF23
      • 4.1.1.16. Others
  • 4.2. North America Fibroblast Growth Factors Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Oncology
      • 4.2.1.2. Hematology
      • 4.2.1.3. Wound Healing
      • 4.2.1.4. Dermatology
      • 4.2.1.5. Cardiovascular Disease & Diabetes
      • 4.2.1.6. Cell Culture
      • 4.2.1.7. Others
  • 4.3. North America Fibroblast Growth Factors Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Pharmaceutical & Biotechnology Companies
      • 4.3.1.2. Research Centers & Academic Institutes
      • 4.3.1.3. CMOs & CDMOs
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis
  • 4.4. North America Fibroblast Growth Factors Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S. Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
      • 4.4.1.2. U.S. Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
      • 4.4.1.3. U.S. Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
      • 4.4.1.4. Canada Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
      • 4.4.1.5. Canada Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
      • 4.4.1.6. Canada Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Fibroblast Growth Factors Market Outlook, 2018 - 2031

  • 5.1. Europe Fibroblast Growth Factors Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. FGF1
      • 5.1.1.2. FGF2
      • 5.1.1.3. FGF3
      • 5.1.1.4. FGF4
      • 5.1.1.5. FGF7
      • 5.1.1.6. FGF10
      • 5.1.1.7. FGF11
      • 5.1.1.8. FGF12
      • 5.1.1.9. FGF13
      • 5.1.1.10. FGF14
      • 5.1.1.11. FGF15
      • 5.1.1.12. FGF18
      • 5.1.1.13. FGF19
      • 5.1.1.14. FGF20
      • 5.1.1.15. FGF23
      • 5.1.1.16. Others
  • 5.2. Europe Fibroblast Growth Factors Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Oncology
      • 5.2.1.2. Hematology
      • 5.2.1.3. Wound Healing
      • 5.2.1.4. Dermatology
      • 5.2.1.5. Cardiovascular Disease & Diabetes
      • 5.2.1.6. Cell Culture
      • 5.2.1.7. Others
  • 5.3. Europe Fibroblast Growth Factors Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Pharmaceutical & Biotechnology Companies
      • 5.3.1.2. Research Centers & Academic Institutes
      • 5.3.1.3. CMOs & CDMOs
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. Europe Fibroblast Growth Factors Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.2. Germany Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.3. Germany Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.4. U.K. Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.5. U.K. Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.6. U.K. Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.7. France Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.8. France Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.9. France Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.10. Italy Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.11. Italy Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.12. Italy Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.13. Turkey Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.14. Turkey Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.15. Turkey Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.16. Russia Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.17. Russia Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.18. Russia Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
      • 5.4.1.19. Rest of Europe Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
      • 5.4.1.20. Rest of Europe Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
      • 5.4.1.21. Rest of Europe Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Fibroblast Growth Factors Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Fibroblast Growth Factors Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. FGF1
      • 6.1.1.2. FGF2
      • 6.1.1.3. FGF3
      • 6.1.1.4. FGF4
      • 6.1.1.5. FGF7
      • 6.1.1.6. FGF10
      • 6.1.1.7. FGF11
      • 6.1.1.8. FGF12
      • 6.1.1.9. FGF13
      • 6.1.1.10. FGF14
      • 6.1.1.11. FGF15
      • 6.1.1.12. FGF18
      • 6.1.1.13. FGF19
      • 6.1.1.14. FGF20
      • 6.1.1.15. FGF23
      • 6.1.1.16. Others
  • 6.2. Asia Pacific Fibroblast Growth Factors Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Oncology
      • 6.2.1.2. Hematology
      • 6.2.1.3. Wound Healing
      • 6.2.1.4. Dermatology
      • 6.2.1.5. Cardiovascular Disease & Diabetes
      • 6.2.1.6. Cell Culture
      • 6.2.1.7. Others
  • 6.3. Asia Pacific Fibroblast Growth Factors Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Pharmaceutical & Biotechnology Companies
      • 6.3.1.2. Research Centers & Academic Institutes
      • 6.3.1.3. CMOs & CDMOs
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Asia Pacific Fibroblast Growth Factors Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.2. China Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.3. China Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.4. Japan Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.5. Japan Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.6. Japan Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.7. South Korea Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.8. South Korea Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.9. South Korea Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.10. India Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.11. India Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.12. India Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.13. Southeast Asia Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.14. Southeast Asia Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.15. Southeast Asia Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
      • 6.4.1.16. Rest of Asia Pacific Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
      • 6.4.1.17. Rest of Asia Pacific Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
      • 6.4.1.18. Rest of Asia Pacific Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Fibroblast Growth Factors Market Outlook, 2018 - 2031

  • 7.1. Latin America Fibroblast Growth Factors Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. FGF1
      • 7.1.1.2. FGF2
      • 7.1.1.3. FGF3
      • 7.1.1.4. FGF4
      • 7.1.1.5. FGF7
      • 7.1.1.6. FGF10
      • 7.1.1.7. FGF11
      • 7.1.1.8. FGF12
      • 7.1.1.9. FGF13
      • 7.1.1.10. FGF14
      • 7.1.1.11. FGF15
      • 7.1.1.12. FGF18
      • 7.1.1.13. FGF19
      • 7.1.1.14. FGF20
      • 7.1.1.15. FGF23
      • 7.1.1.16. Others
  • 7.2. Latin America Fibroblast Growth Factors Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
      • 7.2.1.1. Oncology
      • 7.2.1.2. Hematology
      • 7.2.1.3. Wound Healing
      • 7.2.1.4. Dermatology
      • 7.2.1.5. Cardiovascular Disease & Diabetes
      • 7.2.1.6. Cell Culture
      • 7.2.1.7. Others
  • 7.3. Latin America Fibroblast Growth Factors Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Pharmaceutical & Biotechnology Companies
      • 7.3.1.2. Research Centers & Academic Institutes
      • 7.3.1.3. CMOs & CDMOs
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Latin America Fibroblast Growth Factors Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
      • 7.4.1.2. Brazil Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.4.1.3. Brazil Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.4.1.4. Mexico Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
      • 7.4.1.5. Mexico Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.4.1.6. Mexico Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.4.1.7. Argentina Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
      • 7.4.1.8. Argentina Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.4.1.9. Argentina Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
      • 7.4.1.10. Rest of Latin America Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
      • 7.4.1.11. Rest of Latin America Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
      • 7.4.1.12. Rest of Latin America Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Fibroblast Growth Factors Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Fibroblast Growth Factors Market Outlook, by Product, Value (US$ Mn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. FGF1
      • 8.1.1.2. FGF2
      • 8.1.1.3. FGF3
      • 8.1.1.4. FGF4
      • 8.1.1.5. FGF7
      • 8.1.1.6. FGF10
      • 8.1.1.7. FGF11
      • 8.1.1.8. FGF12
      • 8.1.1.9. FGF13
      • 8.1.1.10. FGF14
      • 8.1.1.11. FGF15
      • 8.1.1.12. FGF18
      • 8.1.1.13. FGF19
      • 8.1.1.14. FGF20
      • 8.1.1.15. FGF23
      • 8.1.1.16. Others
  • 8.2. Middle East & Africa Fibroblast Growth Factors Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Oncology
      • 8.2.1.2. Hematology
      • 8.2.1.3. Wound Healing
      • 8.2.1.4. Dermatology
      • 8.2.1.5. Cardiovascular Disease & Diabetes
      • 8.2.1.6. Cell Culture
      • 8.2.1.7. Others
  • 8.3. Middle East & Africa Fibroblast Growth Factors Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Pharmaceutical & Biotechnology Companies
      • 8.3.1.2. Research Centers & Academic Institutes
      • 8.3.1.3. CMOs & CDMOs
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Middle East & Africa Fibroblast Growth Factors Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.4.1.2. GCC Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.3. GCC Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.4. South Africa Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.4.1.5. South Africa Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.6. South Africa Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.7. Egypt Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.4.1.8. Egypt Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.9. Egypt Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.10. Nigeria Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.4.1.11. Nigeria Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.12. Nigeria Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
      • 8.4.1.13. Rest of Middle East & Africa Fibroblast Growth Factors Market by Product, Value (US$ Mn), 2018 - 2031
      • 8.4.1.14. Rest of Middle East & Africa Fibroblast Growth Factors Market by Application, Value (US$ Mn), 2018 - 2031
      • 8.4.1.15. Rest of Middle East & Africa Fibroblast Growth Factors Market by End User, Value (US$ Mn), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. By End User vs by Application Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientific
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Sigma-Aldrich (now part of Merck KGaA)
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. PeproTech
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. R&D Systems (a Bio-Techne brand)
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Abcam
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Cell Signaling Technology
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Novus Biologicals
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations